Documento de consenso sobre el fenotipo mixto EPOC-asma en la EPOC

This publication has 27 references indexed in Scilit:

• The clinical features of the overlap between COPD and asthma
  Respiratory Research, 2011
• Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology
  Respiratory Research, 2011
• Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD: Table 1–
  European Respiratory Journal, 2010
• Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
  European Respiratory Journal, 2009
• Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
  European Respiratory Journal, 2007
• Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
  European Respiratory Journal, 2006
• Theophylline in Chronic Obstructive Pulmonary Disease: New Horizons
  Proceedings of the American Thoracic Society, 2005
• Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial
  Thorax, 2005
• Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study
  The Lancet, 2000
• The Course and Prognosis of Different Forms of Chronic Airways Obstruction in a Sample from the General Population
  New England Journal of Medicine, 1987